Twycross RGSymptom control: the problem areas. Palliat Med1993; 7 (suppl 1): 1-8.
2.
Levinsky NGFluids and electrolytes. In: Wilson JD, Braunwald E, Isselbacher KJ et al. eds. Harrison's principles of internal medicine , 12th edition. New York: McGraw-Hill, 1991: 279-89.
3.
Gopinathan PM , Pichan G., Sharma VMRole of dehydration in heat stress induced variations in mental performance. Arch Environ Health1988; 43: 15-17.
4.
Shearer S.Dehydration and serum electrolyte changes in South African gold miners with heat disorders. Am J Ind Med1990; 17: 225-39.
5.
Burke AL, Diamond PL, Hulbert J. et al. Terminal restlessness - its management and the role of midazolam . Med JAust1991 ; 155: 485-87.
6.
Bruera E., Miller L., McCallion J., Macmillan K., Krefting L., Hanson J.Cognitive failure (CF) in patients with terminal cancer: a prospective study . J Pain Symptom Manage1992; 7: 192-95.
Anderson RJ, Schrier RWAcute renal failure. In: Wilson JD , Braunwald E, Isselbacher KJ et al. eds. Harrison's principles of internal medicine , 12th edition. New York: McGraw-Hill, 1991: 1144-50.
9.
Hagen NA, Foley KM, Cerbone DJ et al. Chronic nausea and morphine-6-glucuronide. J Pain Sympt Manage1991; 6: 125-28.
10.
Sear JW, Hand CW, Moore RA, McQuay HJStudies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites. Br J Anaesth1989; 62: 28-32.
11.
Peterson GM , Randall CT, Paterson J.Plasma levels of morphine and morphine-glucuronides in the treatment of cancer pain: relationship to renal function and route of administration. Eur J Clin Pharmacol1990 ;38: 121-24.
12.
Fainsinger R. , Bruera E.Hypodermoclysis (HDC) for symptom control vs. the Edmonton Injector (EI). J Palliat Care1991; 7: 5-8.